Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).
Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, Li Gong, Joshua P Lewis, Eun-Young Kim, Daniel Aradi, Israel Fernandez-Cadenas, Richard B Horenstein, Ming Ta Michael Lee, Ryan M Whaley, Joan Montaner, Gian Franco Gensini, John H Cleator, Kiyuk Chang, Lene Holmvang, Willibald Hochholzer, Dan M Roden, Stefan Winter, Russ B Altman, Dimitrios Alexopoulos, Ho-Sook Kim, Jean-Pierre Déry, Meinrad Gawaz, Kevin Bliden, Marco Valgimigli, Rossella Marcucci, Gianluca Campo, Elke Schaeffeler, Nadia P Dridi, Ming-Shien Wen, Jae Gook Shin, Tabassome Simon, Pierre Fontana, Betti Giusti, Tobias Geisler, Michiaki Kubo, Dietmar Trenk, Jolanta M Siller-Matula, Jurriën M Ten Berg, Paul A Gurbel, Jean-Sebastien Hulot, Braxton D Mitchell, Matthias Schwab, Marylyn DeRiggi Ritchie, Teri E Klein, Alan R Shuldiner
American heart journal 2019;198():152-159